Clinical trial · Observational
Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer
NCT02606110CI-TRIAL-00028597withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): PI decided no longer to pursue
Summary
Brief summary (as posted)
The purpose of this study is to investigate the effect of the ReBuilder in the treatment of individuals with breast cancer and chemotherapy induced peripheral neuropathy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Peripheral Neuropathy | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Changes in touch and sensory by way of change in the Semmes-Weinstein Monofilament Testing
- timeFrame
- one year
- measure
- Changes in touch and sensory by way of changes in Functional Gait Assessment
- timeFrame
- One year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with breast cancer referred to Physical Therapy for CIPN * Physical Therapy Examination indicates use of Rebuilder for CIPN * At least 18 years of age * Signed informed consent for study population * Willingness to complete study according to protocol Exclusion Criteria: * Patients who do not have CIPN * Patients \<18 years of age * Inability to or unwilling to sign informed consent * Unable to read and understand the English language * Preexisting sensory peripheral neuropathy from other comorbid conditions such as diabetes or alcoholism * More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days, for sensory peripheral neuropathy
References
Publications (0)
Data not yet available
No reference posted for this study.